Pacifica Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pacifica Partners’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$32.1K	Hold	200	–	–	0.01%	213
2026 Q1	$25.5K	Hold	200	–	–	0.01%	238
2025 Q4	$24.3K	Hold	200	–	–	0.01%	231
2025 Q3	$20.3K	Hold	200	–	–	0.01%	266
2025 Q2	$16.6K	Hold	200	–	–	0.01%	298
2025 Q1	$15.6K	Hold	200	–	–	0.01%	301
2024 Q4	$18.3K	Hold	200	–	–	0.01%	298
2024 Q3	$19.8K	Hold	200	–	–	0.01%	299
2024 Q2	$18.2K	Hold	200	–	–	0.01%	314
2024 Q1	$18.5K	Hold	200	–	–	0.01%	302
2023 Q4	$15.8K	Hold	200	–	–	0.01%	323
2023 Q3	$14.4K	Hold	200	–	–	0.01%	314
2023 Q2	$16.6K	Hold	200	–	–	0.01%	256
2023 Q1	$15.3K	Hold	200	–	–	0.01%	268
2022 Q4	$15.7K	Hold	200	–	–	0.01%	246
2022 Q3	$16K	Hold	200	–	–	0.01%	258
2022 Q2	$15K	Hold	200	–	–	0.01%	274
2022 Q1	$18K	Hold	200	–	–	0.01%	260
2021 Q4	$21K	Hold	200	–	–	0.01%	244
2021 Q3	$26K	Buy	200 +150	+300%	+$19.3K	0.02%	209
2021 Q2	$7K	Hold	50	–	–	0.01%	328
2021 Q1	$7K	Sell	50 -50	-50%	-$7.49K	0.01%	306
2020 Q4	$15K	Buy	+100	New	+$12.8K	0.01%	213

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Pacifica Partners's XBI Position: Q2 2026 in Review

Pacifica Partners held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 200 shares worth $32.1K. The position accounts for 0.01% of the portfolio, ranked #213.

Pacifica Partners first reported a position in XBI in Q4 2020 and has held it in 23 quarters since. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Pacifica Partners held 200 shares of State Street SPDR S&P Biotech ETF worth $32.1K as of Q2 2026.
Pacifica Partners left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Pacifica Partners's portfolio in Q2 2026, its #213 holding.
Pacifica Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 23 quarters since.
260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.